Protecting IP in the Pharmaceutical Industry

Protecting IP in the Pharmaceutical Industry

With the cost of bringing a new drug to market now exceeding $2.5B, it should come as no surprise that pharmaceutical companies are increasingly targeted for their Intellectual Property (IP). As a result, companies are beginning to adopt Incident Response strategies centered around their IP.

Is your company’s Intellectual Property at Risk?

Download This White Paper to Learn:

  • The Importance of  a dedicated IP incident management team
  • The tools and tactics for prioritizing IP security
  • How to identify and assign value to critical IP Assets
  • How to leverage proven incident handling procedures